Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease
Lauro Cortigiani, MDa,
Claudio Dodi, MDa,
Emilio A. Paolini, MDa,
Daniele Bernardi, MDa,
Gabriele Bruno, MDa and
Eugenio Nannini, MDa
a Cardiovascular Units, Hospitals of Lucca and Guastalla, Lucca (Reggio Emilia), Italy

View larger version (13K):
[in a new window]
|
Figure 1 Cumulative survival rates free of hard cardiac events (cardiac death and nonfatal myocardial infarction) in patients with negative (Neg) and positive (Pos) result of stress echocardiography.
|
|

View larger version (13K):
[in a new window]
|
Figure 2 Cumulative survival rates free of spontaneous cardiac events (cardiac death, nonfatal myocardial infarction and unstable angina) in patients with negative (Neg) and positive (Pos) result of stress echocardiography.
|
|

View larger version (14K):
[in a new window]
|
Figure 3 Cumulative survival rates free of spontaneous cardiac events (cardiac death, nonfatal myocardial infarction and unstable angina) according to the presence (+) or absence () of echocardiographic (Echo) or electrocardiographic (ECG) signs of ischemia during pharmacological stress testing.
|
|
|